These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16438640)

  • 1. Serum albumin as a prognostic indicator for HIV disease progression.
    Mehta SH; Astemborski J; Sterling TR; Thomas DL; Vlahov D
    AIDS Res Hum Retroviruses; 2006 Jan; 22(1):14-21. PubMed ID: 16438640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression.
    Tang AM; Graham NM; Chandra RK; Saah AJ
    J Nutr; 1997 Feb; 127(2):345-51. PubMed ID: 9039838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study.
    Sabin CA; Griffioen A; Yee TT; Emery VC; Herrero-Martinez E; Phillips AN; Lee CA
    Lancet; 2002 Nov; 360(9345):1546-51. PubMed ID: 12443592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
    O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
    JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study.
    Vanhems P; Lambert J; Guerra M; Hirschel B; Allard R
    J Infect Dis; 1999 Dec; 180(6):1803-8. PubMed ID: 10558934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
    Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
    J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda.
    Lutalo T; Gray RH; Wawer M; Sewankambo N; Serwadda D; Laeyendecker O; Kiwanuka N; Nalugoda F; Kigozi G; Ndyanabo A; Bwanika JB; Reynolds SJ; Quinn T; Opendi P
    AIDS; 2007 Nov; 21 Suppl 6():S15-9. PubMed ID: 18032934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin and others parameters in intravenous drug users HIV-infected.
    Cirasino L; Landonio G; Imbriani M; Silvani A; Bighellini K; Ragaini S
    Recenti Prog Med; 1992 Jun; 83(6):344-9. PubMed ID: 1496183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe.
    Lancet; 2000 Apr; 355(9210):1131-7. PubMed ID: 10791375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.
    Muga R; Ferreros I; Langohr K; de Olalla PG; Del Romero J; Quintana M; Alastrue I; Belda J; Tor J; Pérez-Hoyos S; Del Amo J;
    AIDS; 2007 Nov; 21(18):2521-7. PubMed ID: 18025889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men.
    Galai N; Vlahov D; Margolick JB; Chen K; Graham NM; Muñoz A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):66-74. PubMed ID: 8548349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
    Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
    Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with gender.
    Shah S; Smith CJ; Lampe F; Youle M; Johnson MA; Phillips AN; Sabin CA
    HIV Med; 2007 Jan; 8(1):38-45. PubMed ID: 17305931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
    Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
    Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
    Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
    Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical manifestations of HIV infection during seroconversion].
    Kravchenko AV; Iurin OG; Buravtsova EV; Pankova GIu; Serebrovskaia LV; Galina MV; Roslyĭ IM; Pokrovskiĭ VV
    Ter Arkh; 1995; 67(11):24-7. PubMed ID: 8571243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
    Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.